Cystic fibrosis and COVID-19: Care considerations

The coronavirus disease 2019 (COVID-19) pandemic has demanded large scale changes in patient care. People with cystic fibrosis have unique considerations, including underlying lung disease and routine aerosolizing therapies, but there is insufficient evidence to create comprehensive practice guideli...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirza, Alicia A., Rad, Elika J., Mohabir, Paul K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492163/
https://www.ncbi.nlm.nih.gov/pubmed/32953446
http://dx.doi.org/10.1016/j.rmcr.2020.101226
_version_ 1783582331873787904
author Mirza, Alicia A.
Rad, Elika J.
Mohabir, Paul K.
author_facet Mirza, Alicia A.
Rad, Elika J.
Mohabir, Paul K.
author_sort Mirza, Alicia A.
collection PubMed
description The coronavirus disease 2019 (COVID-19) pandemic has demanded large scale changes in patient care. People with cystic fibrosis have unique considerations, including underlying lung disease and routine aerosolizing therapies, but there is insufficient evidence to create comprehensive practice guidelines. We share a case of a patient with CF and COVID-19 as well as alterations to routine CF care at a large academic center. Key considerations include accessible COVID-19 screening, augmented infection control practices, and rapid integration of telemedicine.
format Online
Article
Text
id pubmed-7492163
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-74921632020-09-16 Cystic fibrosis and COVID-19: Care considerations Mirza, Alicia A. Rad, Elika J. Mohabir, Paul K. Respir Med Case Rep Case Report The coronavirus disease 2019 (COVID-19) pandemic has demanded large scale changes in patient care. People with cystic fibrosis have unique considerations, including underlying lung disease and routine aerosolizing therapies, but there is insufficient evidence to create comprehensive practice guidelines. We share a case of a patient with CF and COVID-19 as well as alterations to routine CF care at a large academic center. Key considerations include accessible COVID-19 screening, augmented infection control practices, and rapid integration of telemedicine. Elsevier 2020-09-16 /pmc/articles/PMC7492163/ /pubmed/32953446 http://dx.doi.org/10.1016/j.rmcr.2020.101226 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Mirza, Alicia A.
Rad, Elika J.
Mohabir, Paul K.
Cystic fibrosis and COVID-19: Care considerations
title Cystic fibrosis and COVID-19: Care considerations
title_full Cystic fibrosis and COVID-19: Care considerations
title_fullStr Cystic fibrosis and COVID-19: Care considerations
title_full_unstemmed Cystic fibrosis and COVID-19: Care considerations
title_short Cystic fibrosis and COVID-19: Care considerations
title_sort cystic fibrosis and covid-19: care considerations
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492163/
https://www.ncbi.nlm.nih.gov/pubmed/32953446
http://dx.doi.org/10.1016/j.rmcr.2020.101226
work_keys_str_mv AT mirzaaliciaa cysticfibrosisandcovid19careconsiderations
AT radelikaj cysticfibrosisandcovid19careconsiderations
AT mohabirpaulk cysticfibrosisandcovid19careconsiderations

Ejemplares similares